Clinical Trial Update: Fluocinolone Acetonide Intravitreal Inserts in Geographic Atrophy [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing fluocinolone acetonide intravitreal inserts for geographic atrophy due to age-related macular degeneration has been terminated, with r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• ILUVIEN (fluocinolone acetonide)

Snippet

Sponsor: Alimera Sciences | Conditions: Age-Related Macular Degeneration | Phase 2 | Status: TERMINATED | Results posted: 2015-05-29